Search Legislation

The Quality and Safety of Organs Intended for Transplantation Regulations 2012

 Help about what version

What Version

 Help about advanced features

Advanced Features

Changes to legislation:

There are currently no known outstanding effects for the The Quality and Safety of Organs Intended for Transplantation Regulations 2012, Section 3. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

InterpretationU.K.

This section has no associated Explanatory Memorandum

3.[F1(1)]  In these Regulations—

the 2004 Act” means the Human Tissue Act 2004 ;

the 2006 Regulations” means the Human Tissue Act 2004 (Persons who Lack Capacity to Consent and Transplants) Regulations 2006 ;

the 2006 Scotland Act” means the Human Tissue (Scotland) Act 2006 ;

the 2006 Scotland Regulations” means the Human Organ and Tissue Live Transplants (Scotland) Regulations 2006 ;

the 2007 Regulations” means the Human Tissue (Quality and Safety for Human Application) Regulations 2007 ;

the Authority” means the Human Tissue Authority established under section 13 of the 2004 Act;

“consent”, in respect of a donor, means [F2, where retrieval of an organ takes place]

(a)

in England [F3or] Northern Ireland, appropriate consent as defined in the 2004 Act ; F4...

(b)

in Scotland, the authorisation referred to in Part 1 (transplantation etc.) of the 2006 Scotland Act or, as the case may be, the authorisation or lack of unwillingness of the donor referred to in the 2006 Scotland Regulations [F5; or

(c)

in Wales, express consent where that is required under any of sections 4 to 7 of the Human Transplantation (Wales) Act 2013 or, where express consent is not required, deemed consent under section 4 or 9 of that Act;]

the Directive ” means Directive 2010/53/EU of the European Parliament and of the Council of 7th July 2010 on standards of quality and safety of human organs intended for transplantation [F6, as it applies in relation to Northern Ireland];

disposal” means the final placement of an organ where it is not used for transplantation;

donation” means donating organs for the purposes of transplantation;

donor” means a person who donates one or several organs, whether donation occurs during lifetime or after death;

donor characterisation” means the collection of relevant information on the characteristics of the donor needed to evaluate the donor's suitability for donation, in order to undertake a risk assessment and to minimise the risks for the recipient, and optimise organ allocation;

[F7“the Implementing Directive” means Commission Implementing Directive 2012/25/EU laying down information procedures for the exchange, between Member States, of human organs intended for transplantation [F8, as it applies in relation to Northern Ireland;]]

licensed activity”, in relation to a licence, means an activity which the licence authorises under Schedule 1;

licence holder” means a person who holds a licence under Schedule 1;

organ” means a differentiated part of the human body, formed by different tissues, that maintains its structure, vascularisation, and capacity to develop physiological functions with a significant level of autonomy; and a part of an organ is also considered to be an organ if its function is to be used for the same purpose as the entire organ in the human body, maintaining the requirements of structure and vascularisation;

organ characterisation” means the collection of the relevant information on the characteristics of the organ needed to evaluate its suitability for transplantation, in order to undertake a risk assessment and minimise the risks for the recipient, and optimise organ allocation;

operating procedures” means written instructions describing the steps in a specific process, including the materials and methods to be used and the expected end outcome;

preservation” means the use of chemical agents, alterations in environmental conditions or other means to prevent or retard biological or physical deterioration of organs from procurement to transplantation;

procurement” means a process by which a donated organ becomes available for transplantation;

procurement activity” means all or any of the following activities, undertaken for the purposes of procurement—

(a)

donor characterisation;

(b)

organ characterisation;

(c)

preservation of an organ;

(d)

making arrangements to transport an organ;

(e)

retrieval of an organ;

[F9procurement organisation” means a healthcare establishment, a team or a unit of a hospital, a person, or any other body which undertakes or coordinates the procurement of organs, and is authorised to do so by the Authority;]

recipient” means a person who receives a transplant of an organ;

serious adverse event” means any undesired and unexpected occurrence associated with any stage of the chain from donation to transplantation that might lead to the transmission of a communicable disease, to death or life-threatening, disabling or incapacitating conditions for a patient or which results in, or prolongs, hospitalisation or morbidity;

serious adverse reaction” means an unintended response, including a communicable disease, in the living donor or in the recipient that might be associated with any stage of the chain from donation to transplantation that is fatal, life-threatening, disabling, incapacitating, or which results in, or prolongs, hospitalisation or morbidity;

traceability” means the ability to locate and identify the organ at each stage in the chain from donation to transplantation or disposal, including the ability to—

(a)

identify the donor and the licence holder who retrieved the organ from the donor;

(b)

identify the licence holder who implanted the organ in the recipient;

(c)

identify the recipient at the premises at which the organ is implanted into the recipient; and

(d)

locate and identify all relevant non-personal information relating to products and materials coming into contact with that organ;

transplantation” means a process which is intended to restore certain functions of the human body by transferring an organ from a donor to a recipient; and

transplantation activity” means all or any of the following activities, undertaken for the purposes of transplantation—

(a)

organ characterisation;

(b)

preservation of an organ;

(c)

making arrangements to transport an organ;

(d)

implantation of an organ.

[F10(2) In these Regulations, as they apply in relation to Great Britain, a reference to ensuring compliance with these Regulations includes a reference to ensuring compatibility with the principles set out in Article 13 of Directive 2010/53/EU of the European Parliament and of the Council on standards of quality and safety of human organs intended for transplantation as modified by section 32(3C) of the 2004 Act.]

Textual Amendments

F2Words in reg. 3 inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Human Transplantation (Wales) Act 2013 (Consequential Provision) Order 2015 (S.I. 2015/865), arts. 1(2), 3(a)

F3Word in reg. 3 substituted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Human Transplantation (Wales) Act 2013 (Consequential Provision) Order 2015 (S.I. 2015/865), arts. 1(2), 3(b)(i)

F4Word in reg. 3 omitted (coming into force in accordance with art. 1(2) of the amending S.I.) by virtue of The Human Transplantation (Wales) Act 2013 (Consequential Provision) Order 2015 (S.I. 2015/865), arts. 1(2), 3(b)(ii)

F5Words in reg. 3 added (coming into force in accordance with art. 1(2) of the amending S.I.) by The Human Transplantation (Wales) Act 2013 (Consequential Provision) Order 2015 (S.I. 2015/865), arts. 1(2), 3(c)

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources